JP2009529509A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009529509A5 JP2009529509A5 JP2008557672A JP2008557672A JP2009529509A5 JP 2009529509 A5 JP2009529509 A5 JP 2009529509A5 JP 2008557672 A JP2008557672 A JP 2008557672A JP 2008557672 A JP2008557672 A JP 2008557672A JP 2009529509 A5 JP2009529509 A5 JP 2009529509A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- peptide
- natural
- amino
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000001014 amino acid Nutrition 0.000 claims 124
- 229940024606 amino acid Drugs 0.000 claims 123
- 150000001413 amino acids Chemical class 0.000 claims 122
- 108090000765 processed proteins & peptides Proteins 0.000 claims 45
- 238000006467 substitution reaction Methods 0.000 claims 18
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 12
- LMYNKFDVIZBWDF-UHFFFAOYSA-N 2-azaniumyl-4-bromobutanoate Chemical compound OC(=O)C(N)CCBr LMYNKFDVIZBWDF-UHFFFAOYSA-N 0.000 claims 11
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 11
- 239000004472 Lysine Substances 0.000 claims 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 108091035707 Consensus sequence Proteins 0.000 claims 7
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 7
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 7
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 7
- 230000000694 effects Effects 0.000 claims 7
- 229960003104 ornithine Drugs 0.000 claims 7
- KFHRMMHGGBCRIV-BYPYZUCNSA-N (2s)-2-azaniumyl-4-methoxybutanoate Chemical compound COCC[C@H](N)C(O)=O KFHRMMHGGBCRIV-BYPYZUCNSA-N 0.000 claims 6
- JUQLUIFNNFIIKC-UHFFFAOYSA-N 2-aminopimelic acid Chemical compound OC(=O)C(N)CCCCC(O)=O JUQLUIFNNFIIKC-UHFFFAOYSA-N 0.000 claims 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 6
- 125000003636 chemical group Chemical group 0.000 claims 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims 6
- 150000003147 proline derivatives Chemical class 0.000 claims 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 5
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 5
- QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 claims 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 5
- QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 claims 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 5
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 5
- 239000004473 Threonine Substances 0.000 claims 5
- 229960001230 asparagine Drugs 0.000 claims 5
- 235000009582 asparagine Nutrition 0.000 claims 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 5
- 229930182852 proteinogenic amino acid Natural products 0.000 claims 5
- IYKLZBIWFXPUCS-VIFPVBQESA-N (2s)-2-(naphthalen-1-ylamino)propanoic acid Chemical compound C1=CC=C2C(N[C@@H](C)C(O)=O)=CC=CC2=C1 IYKLZBIWFXPUCS-VIFPVBQESA-N 0.000 claims 4
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 3
- 239000000556 agonist Substances 0.000 claims 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 239000000539 dimer Substances 0.000 claims 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 3
- 125000001433 C-terminal amino-acid group Chemical group 0.000 claims 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 2
- 230000001747 exhibiting effect Effects 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 239000000470 constituent Substances 0.000 claims 1
- 230000000447 dimerizing effect Effects 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78056806P | 2006-03-09 | 2006-03-09 | |
| EP06004833 | 2006-03-09 | ||
| US74751506P | 2006-05-17 | 2006-05-17 | |
| EP06010174 | 2006-05-17 | ||
| PCT/EP2007/002068 WO2007101698A2 (en) | 2006-03-09 | 2007-03-09 | Modified molecules which promote hematopoiesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009529509A JP2009529509A (ja) | 2009-08-20 |
| JP2009529509A5 true JP2009529509A5 (enExample) | 2010-02-25 |
Family
ID=38475217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008557672A Pending JP2009529509A (ja) | 2006-03-09 | 2007-03-09 | 造血を促進する修飾分子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090281278A1 (enExample) |
| EP (1) | EP2007791A2 (enExample) |
| JP (1) | JP2009529509A (enExample) |
| AU (1) | AU2007222526A1 (enExample) |
| BR (1) | BRPI0709014A2 (enExample) |
| CA (1) | CA2680228A1 (enExample) |
| IL (1) | IL193773A0 (enExample) |
| MX (1) | MX2008011389A (enExample) |
| SG (1) | SG170086A1 (enExample) |
| WO (1) | WO2007101698A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7589063B2 (en) | 2004-12-14 | 2009-09-15 | Aplagen Gmbh | Molecules which promote hematopoiesis |
| JP2009242372A (ja) * | 2008-03-11 | 2009-10-22 | Yokohama City Univ | 均一な糖鎖構造を有するエリスロポエチン誘導体 |
| CN102238966B (zh) | 2008-12-06 | 2014-08-06 | 贝朗医疗有限公司 | 转运介导的胶体药用化合物 |
| US9056085B2 (en) * | 2009-02-03 | 2015-06-16 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
| US9051548B2 (en) | 2009-02-03 | 2015-06-09 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
| WO2010136242A1 (de) * | 2009-03-31 | 2010-12-02 | B. Braun Melsungen Ag | Verknüpfungsprodukte aminierter polysaccharide |
| WO2011012306A2 (en) | 2009-07-30 | 2011-02-03 | Aplagen Gmbh | Use of emps for antagonising epo-stimulatory effects on epo-responsive tumors while maintaining erythropoiesis |
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| CN104231067B (zh) * | 2013-06-07 | 2017-08-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 促红细胞生成素模拟肽化学二聚体及其用途 |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| EP3909603A1 (en) | 2014-02-21 | 2021-11-17 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Glycotargeting therapeutics |
| US11253579B2 (en) | 2017-06-16 | 2022-02-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| JP2021528371A (ja) | 2018-05-09 | 2021-10-21 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | 免疫寛容に関する組成物および方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3924746A1 (de) * | 1989-07-26 | 1991-01-31 | Behringwerke Ag | Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper |
| US5747446A (en) * | 1994-03-22 | 1998-05-05 | Beth Israel Deaconess Medical Center | Modified polypeptides with increased biological activity |
| CN1192748A (zh) * | 1995-06-07 | 1998-09-09 | 奥尔托药品有限公司 | 与红细胞生成素受体结合的化合物和肽 |
| AU2003215732B2 (en) * | 2002-03-01 | 2009-12-17 | Immunomedics, Inc. | Internalizing anti-CD74 antibodies and methods of use |
| WO2004002424A2 (en) * | 2002-06-28 | 2004-01-08 | Centocor, Inc. | Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| WO2004101600A2 (en) * | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Novel poly(ethylene glycol) modified compounds and uses thereof |
| US20070275871A1 (en) * | 2003-08-28 | 2007-11-29 | Biorexis Technology, Inc. | Epo Mimetic Peptides and Fusion Proteins |
| JP2008519589A (ja) * | 2004-11-10 | 2008-06-12 | アプラゲン ゲーエムベーハー | 造血を促進する分子 |
| WO2006062685A2 (en) * | 2004-11-11 | 2006-06-15 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
| JP2008546732A (ja) * | 2005-06-23 | 2008-12-25 | アプラゲン ゲーエムベーハー | 多価化合物 |
-
2007
- 2007-03-09 MX MX2008011389A patent/MX2008011389A/es not_active Application Discontinuation
- 2007-03-09 AU AU2007222526A patent/AU2007222526A1/en not_active Abandoned
- 2007-03-09 SG SG201101682-1A patent/SG170086A1/en unknown
- 2007-03-09 CA CA002680228A patent/CA2680228A1/en not_active Abandoned
- 2007-03-09 EP EP07711874A patent/EP2007791A2/en not_active Withdrawn
- 2007-03-09 JP JP2008557672A patent/JP2009529509A/ja active Pending
- 2007-03-09 BR BRPI0709014-5A patent/BRPI0709014A2/pt not_active IP Right Cessation
- 2007-03-09 US US12/281,565 patent/US20090281278A1/en not_active Abandoned
- 2007-03-09 WO PCT/EP2007/002068 patent/WO2007101698A2/en not_active Ceased
-
2008
- 2008-08-31 IL IL193773A patent/IL193773A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009529509A5 (enExample) | ||
| JP2019501647A5 (enExample) | ||
| ES2573108T3 (es) | Proteínas de armazón a base de fibronectina que tienen estabilidad mejorada | |
| HRP20210990T1 (hr) | Proteini okosnične domene na bazi fibronektina koji se vežu na miostatin | |
| JP2008519589A5 (enExample) | ||
| JP2016052315A5 (enExample) | ||
| JP2013518115A5 (enExample) | ||
| JP2010534486A5 (enExample) | ||
| JP2014501510A5 (enExample) | ||
| JP2011501951A5 (enExample) | ||
| JP2019522465A5 (enExample) | ||
| JP2020502051A5 (enExample) | ||
| JP2012530145A5 (enExample) | ||
| JP2016000731A5 (enExample) | ||
| JP2019535268A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| RU2017134456A (ru) | Рекомбинантные связывающие белки и их применение | |
| JP2015525217A5 (enExample) | ||
| JP2016512213A5 (enExample) | ||
| JP2018521640A5 (enExample) | ||
| JP2006502741A5 (enExample) | ||
| JP2010539915A5 (enExample) | ||
| JP2014508510A5 (enExample) | ||
| JP2018538356A5 (enExample) | ||
| JP2012531889A5 (enExample) | ||
| JP2013534812A5 (enExample) |